Earnings Watch: AMD, Novo Nordisk, and Apple

Earnings Watch: AMD, Novo Nordisk, and Apple

Picture of Peter Garnry
Peter Garnry

Chief Investment Strategist

Summary:  The Q1 earnings season has been better than feared showing companies that are still confident about the outlook and the technology sector is showing so far that operating income is growing again following significant cost-cutting. In this week's earnings we focus on AMD, Novo Nordisk, and Apple where all three companies face quite steep expectations from investors following strong share price performances this year.


Technology is back in growth mode

The significant amount of cost-cutting among technology companies is beginning to yield results for technology companies with Nasdaq 100 expanding EBITDA in Q1 q/q while both the S&P 500 and the STOXX 600 are so far reporting declines in EBITDA q/q. Another key observation is that European companies continue to do well relative to US companies underpinning the case for European equities this year. The US companies are always leading the earnings season so these conclusions may change before the season is over and this week’s results from AMD and Apple could change the positive turnaround in operating income that we are observing so far in the Nasdaq 100. While US equities have come back recently, the main risk and issue with US equities remain the high equity valuation relative to other equity markets and with a 12-month 12.8x EV/EBITDA the US equity market comes with a significant valuation premium to global equities.

1_PG_1

Another busy earnings week with focus on AMD, Novo Nordisk, and Apple

The three stocks we are focusing on for this week’s earnings releases are AMD, Novo Nordisk, and Apple because there are all popular companies, with strong growth record, and important for their respective industries.

Will AMD continue to ride the AI hype?

AMD reports Q1 earnings tomorrow after the US market close with analysts expecting revenue of $5.3bn down 10% y/y and EBITDA of $1.27bn down from $1.71bn a year ago reflecting increased input costs and lower demand as corporate technology spending is declining and gaming is not as hot as during the pandemic. With expectations set low for Q1 we expect AMD to clear this bar easily, but expectations are certainly steeper for the coming quarters as the AI hype with ChatGPT has lifted AMD’s share price 38% this year and thus the Q2 guidance will be key for the market’s reaction.

Novo Nordisk is up against extreme expectations

Novo Nordisk reports Q1 earnings on Thursday before the market opens in Copenhagen with analysts expecting Q1 revenue of DKK 51.8bn up 23% y/y and EBITDA of DKK 25bn up from DKK 20.8bn a year ago driven by strong growth in the company’s weight loss drug Wegovy. Back in early February we wrote a game changer equity note on Novo Nordisk with a special focus on Wegovy as the company’s next important growth driver. Novo Nordisk has got a head start on this new class of weight loss drugs with Eli Lilly waiting for its FDA approval and the market is really excited about the growth outlook sending Novo Nordisk shares up 21% this year.

Can Apple get back to above average growth?

Apple reports FY23 Q2 earnings (ending 31 March) on Thursday after the market close with analysts expecting revenue of $92.6bn down 5% y/y and EBITDA of $30.2bn down from $32.7bn a year ago as input costs remain hot demand has been negatively impacted by high inflation in key markets reducing consumers appetite for Apple’s pricier electronic devices such as the iPhone. We expect Apple to guide weak Mac sales and the risk has gone up that iPhone guidance could disappoint as well. With the share price up 31% this year expectations might be too high for even Apple.

1_PG_2
AMD, Novo Nordisk, and Apple weekly total return the past five years | Source: Bloomberg

The list below shows all the most important earnings releases to watch this week with especially Thursday being the main course with key earnings from Shopify on e-commerce, Maersk on logistics, Volkswagen and BMW on EV growth, Infineon on semiconductor pick-up, Rheinmetall on EU military spending, Zalando on EU consumer spending, Shell on energy markets, ArcelorMittal on steel demand, Booking on travel, Ferrari on luxury, and lastly Fortinet on cyber security.

  • Monday: Berkshire Hathaway, Stryker, Vertex Pharmaceuticals, NXP Semiconductors

  • Tuesday: Thomson Reuters, HSBC, BP, DBS Group, Geberit, Pfizer, AMD, Starbucks, Uber Technologies, Marathon Petroleum, Ford Motor

  • Wednesday: Barrick Gold, Orsted, Airbus, BNP Paribas, Deutsche Post, Enel, UniCredit, Lloyds Banking Group, Qualcomm, CVS Health, Estee Lauder, MercadoLibre, Kraft Heinz

  • Thursday: National Australia Bank, Anheuser-Busch InBev, Shopify, Novo Nordisk, Maersk, Volkswagen, BMW, Infineon Technologies, Uniper, Rheinmetall, Zalando, Shell, ArcelorMittal, Equinor, Apple, ConocoPhillips, Booking, Regeneron Pharmaceuticals, Zoetis, Becton Dickinson, EOG Resources, Ferrari, Fortinet

  • Friday: ANZ, Macquire Group, Enbridge, Canadian Natural Resources, Adidas, Intesa Sanpaolo, CaixaBank, Cigna Group

Quarterly Outlook

01 /

  • Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    Quarterly Outlook

    Macro outlook: Trump 2.0: Can the US have its cake and eat it, too?

    John J. Hardy

    Global Head of Macro Strategy

  • Equity Outlook: The ride just got rougher

    Quarterly Outlook

    Equity Outlook: The ride just got rougher

    Charu Chanana

    Chief Investment Strategist

  • China Outlook: The choice between retaliation or de-escalation

    Quarterly Outlook

    China Outlook: The choice between retaliation or de-escalation

    Charu Chanana

    Chief Investment Strategist

  • Commodity Outlook: A bumpy road ahead calls for diversification

    Quarterly Outlook

    Commodity Outlook: A bumpy road ahead calls for diversification

    Ole Hansen

    Head of Commodity Strategy

  • FX outlook: Tariffs drive USD strength, until...?

    Quarterly Outlook

    FX outlook: Tariffs drive USD strength, until...?

    John J. Hardy

    Global Head of Macro Strategy

  • Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Quarterly Outlook

    Fixed Income Outlook: Bonds Hit Reset. A New Equilibrium Emerges

    Althea Spinozzi

    Head of Fixed Income Strategy

  • Equity Outlook: Will lower rates lift all boats in equities?

    Quarterly Outlook

    Equity Outlook: Will lower rates lift all boats in equities?

    Peter Garnry

    Chief Investment Strategist

    After a period of historically high equity index concentration driven by the 'Magnificent Seven' sto...
  • Commodity Outlook: Gold and silver continue to shine bright

    Quarterly Outlook

    Commodity Outlook: Gold and silver continue to shine bright

    Ole Hansen

    Head of Commodity Strategy

  • Macro Outlook: The US rate cut cycle has begun

    Quarterly Outlook

    Macro Outlook: The US rate cut cycle has begun

    Peter Garnry

    Chief Investment Strategist

    The Fed started the US rate cut cycle in Q3 and in this macro outlook we will explore how the rate c...
  • FX Outlook: USD in limbo amid political and policy jitters

    Quarterly Outlook

    FX Outlook: USD in limbo amid political and policy jitters

    Charu Chanana

    Chief Investment Strategist

    As we enter the final quarter of 2024, currency markets are set for heightened turbulence due to US ...

Content disclaimer

None of the information provided on this website constitutes an offer, solicitation, or endorsement to buy or sell any financial instrument, nor is it financial, investment, or trading advice. Saxo Bank A/S and its entities within the Saxo Bank Group provide execution-only services, with all trades and investments based on self-directed decisions. Analysis, research, and educational content is for informational purposes only and should not be considered advice nor a recommendation.

Saxo’s content may reflect the personal views of the author, which are subject to change without notice. Mentions of specific financial products are for illustrative purposes only and may serve to clarify financial literacy topics. Content classified as investment research is marketing material and does not meet legal requirements for independent research.

Before making any investment decisions, you should assess your own financial situation, needs, and objectives, and consider seeking independent professional advice. Saxo does not guarantee the accuracy or completeness of any information provided and assumes no liability for any errors, omissions, losses, or damages resulting from the use of this information.

Please refer to our full disclaimer and notification on non-independent investment research for more details.
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/legal/disclaimer/saxo-disclaimer)

Saxo Bank A/S (Headquarters)
Philip Heymans Alle 15
2900
Hellerup
Denmark

Contact Saxo

Select region

International
International

All trading and investing comes with risk, including but not limited to the potential to lose your entire invested amount.

Information on our international website (as selected from the globe drop-down) can be accessed worldwide and relates to Saxo Bank A/S as the parent company of the Saxo Bank Group. Any mention of the Saxo Bank Group refers to the overall organisation, including subsidiaries and branches under Saxo Bank A/S. Client agreements are made with the relevant Saxo entity based on your country of residence and are governed by the applicable laws of that entity's jurisdiction.

Apple and the Apple logo are trademarks of Apple Inc., registered in the US and other countries. App Store is a service mark of Apple Inc. Google Play and the Google Play logo are trademarks of Google LLC.